Published in Medical Letter on the CDC and FDA, August 30th, 2009
BIOPATCH® is placed directly on the skin at the point of catheter insertion and provides seven days of continuous active antisepsis. In a clinical...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.